Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Adami, Eleonora Dr. (1) Akalin, Altuna Dr. (1) Blachut, Susanne (1) Daumke, Oliver Prof. Dr. (1) Diecke, Sebastian Dr. (9) Franke, Vedran Dr. (1) Hummel, Oliver (1) Kirchner, Marieluise Dr. (1) Kolesnichenko, Marina Dr. (1) Landthaler, Markus Prof. Dr. (1) Lindberg, Eric Lars-Helge (1) Lisowski, Pawel Dr. (1) Maatz, Henrike Dr. (1) Mertins, Philipp Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (1) Patone, Giannino Dr. (2) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Wollert-Wulf, Brigitte (1) Wyler, Emanuel Dr. (1) (-) Hübner, Norbert Prof. Dr. (2) (-) Janz, Martin Dr. (6) (-) Mathas, Stephan Dr. (11) (-) Scheidereit, Claus Prof. Dr. (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (3) 2004 (3) 2005 (3) 2006 (5) 2007 (4) 2008 (4) 2009 (4) 2010 (3) (-) 2011 (4) 2012 (2) 2013 (3) 2014 (2) (-) 2015 (5) 2016 (3) 2017 (5) 2018 (1) (-) 2019 (3) 2020 (6) 2021 (3) 2022 (8) 2023 (10) 2024 (2) AG Müller/Dechend (ECRC) (2) Anchored Signalling (1) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (11) Cancer Genetics and Cellular Stress Responses (1) Computational Regulatory Genomics (1) Genetics and Genomics of Cardiovascular Diseases (41) Hypertension-caused End-Organ Damage (2) Hypertension-Mediated End-Organ Damage (2) Immune Regulation and Cancer (1) Mathematical Modelling of Cellular Processes (1) Molecular Biology of Peptide Hormones (1) Molecular Genetics of Chronic Inflammation and Allergic Disease (7) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (7) (-) Pluripotent Stem Cells (1) Protein Production and Characterization (1) Proteome Dynamics (2) Proteomics (1) Proteomics and Metabolomics (1) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) RNA Biology and Posttranscriptional Regulation (3) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (3) Translational Cardiology and Functional Genomics (1) Tumor heterogeneity and treatment resistance in pediatric cancer (1) 12 Results: Active Filter: Hübner, Norbert Prof. Dr.Janz, Martin Dr.Mathas, Stephan Dr.Scheidereit, Claus Prof. Dr.Biology of Malignant LymphomasPluripotent Stem Cells201120152019 Sort: Result score Newest to oldest Oldest to newest June 27, 2019 / Cell The translational landscape of the human heart S. van Heesch F. Witte V. Schneider-Lunitz J.F. Schulz E. Adami A. Faber M. Kirchner H. Maatz S. Blachut C.L. Sandmann M. Kanda C.L. Worth S. Schafer L. Calviello R. Merriott G. Patone O. Hummel E. Wyler B. Obermayer M. Mücke E.L. Lindberg F. Trnka S. Memczak M. Schilling L.E. Felkin P.J.R. Barton N.M. Quaife K. Vanezis S. Diecke M. Mukai N. Mah S.J. Oh A. Kurtz C. Schramm D. Schwinge M. Sebode M. Harakalova F.W. Asselbergs A. Vink R.A. de Weger S. Viswanathan A.A. Widjaja A. Gärtner-Rommel H. Milting C. Dos Remedios C. Knosalla P. Mertins M. Landthaler M. Vingron W.A. Linke J.G. Seidman C.E. Seidman N. Rajewsky U. Ohler S.A. Cook N. Hubner August 01, 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf April 14, 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas June 01, 2019 / Leukemia Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma B. Edginton-White P. Cauchy S.A. Assi S. Hartmann A.G. Riggs S. Mathas P.N. Cockerill C. Bonifer March 28, 2019 / Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit June 01, 2015 / Front Biosci The origins of ALK translocations V. Roukos S. Mathas July 14, 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz November 01, 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas April 11, 2015 / Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert January 01, 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz Pagination Current page 1 Page 2 Next page Next › Last page Last »
June 27, 2019 / Cell The translational landscape of the human heart S. van Heesch F. Witte V. Schneider-Lunitz J.F. Schulz E. Adami A. Faber M. Kirchner H. Maatz S. Blachut C.L. Sandmann M. Kanda C.L. Worth S. Schafer L. Calviello R. Merriott G. Patone O. Hummel E. Wyler B. Obermayer M. Mücke E.L. Lindberg F. Trnka S. Memczak M. Schilling L.E. Felkin P.J.R. Barton N.M. Quaife K. Vanezis S. Diecke M. Mukai N. Mah S.J. Oh A. Kurtz C. Schramm D. Schwinge M. Sebode M. Harakalova F.W. Asselbergs A. Vink R.A. de Weger S. Viswanathan A.A. Widjaja A. Gärtner-Rommel H. Milting C. Dos Remedios C. Knosalla P. Mertins M. Landthaler M. Vingron W.A. Linke J.G. Seidman C.E. Seidman N. Rajewsky U. Ohler S.A. Cook N. Hubner
August 01, 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf
April 14, 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas
June 01, 2019 / Leukemia Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma B. Edginton-White P. Cauchy S.A. Assi S. Hartmann A.G. Riggs S. Mathas P.N. Cockerill C. Bonifer
March 28, 2019 / Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit
July 14, 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz
November 01, 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas
April 11, 2015 / Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert
January 01, 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz